Can a common diabetes drug help kidney patients avoid anemia?
NCT ID NCT07063316
Summary
This large study in Japan is investigating whether SGLT2 inhibitor drugs, often used for diabetes, can help delay or reduce anemia in people with chronic kidney disease (CKD). Researchers will compare 15,000 patients who take these drugs with those who do not, tracking when anemia develops and what treatments are needed. The goal is to see if these medications can help control a common and burdensome complication of CKD.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nippon Boehringer Ingelheim Co ., Ltd.
Tokyo, 1416017, Japan
Conditions
Explore the condition pages connected to this study.